10d
Investor's Business Daily on MSNThis Drug Stock Sits On A Strong Earnings Foundation As It Tests New EntryThis pharma stock has made strong gains over the past 12 months thanks to its strong earnings. Now it is testing a fresh buy ...
By employing a particularly effective and precisely tailored catalyst, the researchers were ... including the antiepileptic drug pregabalin. Chirality, or the asymmetric arrangement of atoms ...
Hetero and Lupin); subsequently in 10/2023 a fourth generic drug manufacturer (Inventia) joined the fray. Catalyst settled with Inventia in 07/2024. The settlement provided Inventia's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results